Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 16 | Hart IlanChief Financial Officer | Tax withholding | F | $216K 24.4K sh | Nov 4, 2026 |
| 16 | Rabinowitz DanielSEC. AND CHIEF LEGAL OFFICER | Open-market sale · 10b5-1 plan | SELL | $134K 334 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 16 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | Open-market sale · 10b5-1 plan | SELL | $100K 240 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 16 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | Open-market sale · 10b5-1 plan | SELL | $164K 410 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 16 | George Jennifer LSEVP and COO | Option exercise | M | $56K 2,110 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 16 | DeWitte JacobDirector, Co-Founder, CEO, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $172K 6,700 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 16 | DeWitte JacobDirector, Co-Founder, CEO, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $172K 6,700 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 16 | Fesko JohnPRESIDENT, CHIEF BUS. OFFICER | Open-market sale · 10b5-1 plan | SELL | $118K 295 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 16 | Hovnanian Alexander A.President | Tax withholding | F | $229K 2,185 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 16 | Bidzos D JamesDirector, Exec. Chairman, Pres, & CEO | Open-market sale · 10b5-1 plan | SELL | $357K 1,160 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 16 | Turner KamiChief Accounting Officer | Option exercise | M | $101K 4,500 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 16 | Turner KamiChief Accounting Officer | Option exercise | M | $134K 7,600 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 16 | Cochran CarolineDirector, Co-Founder, COO, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $172K 6,700 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 16 | Bhutani Amanpal SinghDirector, Chief Executive Officer | Open-market sale · 10b5-1 plan | SELL | $530K 4,500 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 16 | Kasbar Michael JDirector, Executive Chairman | Open-market sale · 10b5-1 plan | SELL | $292K 8,062 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 16 | Leach BryanDirector, CEO AND PRESIDENT, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $150K 2,738 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 16 | Peabody MarkExecutive VP & Pres-Aerospace | Option exercise | M | $128K 4,820 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 16 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | Open-market sale · 10b5-1 plan | SELL | $166K 408 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 16 | Berry Jason MEVP & Chief Operating Officer | Tax withholding | F | $59K 1,540 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 16 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | Open-market sale · 10b5-1 plan | SELL | $176K 432 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 16 | Yi StevenDirector, See Remarks | Open-market sale · 10b5-1 plan | SELL | $1.96M 130.1K sh | Nov 4, 2026 traded Nov 3, 2026 |
| 16 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | Open-market sale · 10b5-1 plan | SELL | $213K 520 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 16 | Nonko EugeneDirector | Open-market sale · 10b5-1 plan | SELL | $1.43M 93.3K sh | Nov 4, 2026 traded Nov 4, 2026 |
| 16 | Brophy Michael BurkesCHIEF FINANCIAL OFFICER | Open-market sale · 10b5-1 plan | SELL | $127K 317 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 16 | Yi StevenDirector, See Remarks | Open-market sale · 10b5-1 plan | SELL | $2.34M 151.1K sh | Nov 4, 2026 traded Nov 4, 2026 |
| 16 | Southern Cross Acquisition II Sponsor Corp.10% Owner | Other acquisition or disposition | J | — 324.1K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 16 | Kossover AmyChief Accounting Officer | Tax withholding | F | $61K 10.2K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 16 | Cochran CarolineDirector, Co-Founder, COO, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $172K 6,700 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 16 | Swanson Luke RoyCHIEF TECHNOLOGY OFFICER | Open-market sale · 10b5-1 plan | SELL | $185K 3,094 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 16 | Swanson Luke RoyCHIEF TECHNOLOGY OFFICER | Open-market sale · 10b5-1 plan | SELL | $212K 3,283 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 16 | Costello Beth AnnEVP and CFO | Option exercise · 10b5-1 plan | M | $1.70M 31.6K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 16 | Reed David L.EVP & CFO | Tax withholding | F | $81K 345 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 16 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | Open-market sale · 10b5-1 plan | SELL | $81K 200 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 16 | Daspit MarisaCHIEF PEOPLE OFFICER | Open-market sale · 10b5-1 plan | SELL | $36K 720 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 15 | ten Bosch John RoderickSVP of Laboratory Operations | Open-market sale · 10b5-1 plan | SELL | $160K 1,417 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 15 | ten Bosch John RoderickSVP of Laboratory Operations | Open-market sale · 10b5-1 plan | SELL | $160K 1,417 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 15 | Tsao DavidDirector, Chief Technology Officer | Open-market sale · 10b5-1 plan | SELL | $219K 1,992 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 15 | Tsao DavidDirector, Chief Technology Officer | Open-market sale · 10b5-1 plan | SELL | $114K 1,063 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 15 | Tsao DavidDirector, Chief Technology Officer | Open-market sale · 10b5-1 plan | SELL | $125K 1,130 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 15 | Hovnanian Ara KDirector, Chairman of the Board & CEO, 10% Owner | Tax withholding | F | $458K 4,368 sh | Nov 4, 2026 traded Nov 2, 2026 |